These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26725323)

  • 1. KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation.
    Han XR; Zha Z; Yuan HX; Feng X; Xia YK; Lei QY; Guan KL; Xiong Y
    Oncogene; 2016 Aug; 35(32):4179-90. PubMed ID: 26725323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FBXL10/KDM2B scaffolding protein associates with novel polycomb repressive complex-1 to regulate adipogenesis.
    Inagaki T; Iwasaki S; Matsumura Y; Kawamura T; Tanaka T; Abe Y; Yamasaki A; Tsurutani Y; Yoshida A; Chikaoka Y; Nakamura K; Magoori K; Nakaki R; Osborne TF; Fukami K; Aburatani H; Kodama T; Sakai J
    J Biol Chem; 2015 Feb; 290(7):4163-77. PubMed ID: 25533466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation.
    Wu X; Johansen JV; Helin K
    Mol Cell; 2013 Mar; 49(6):1134-46. PubMed ID: 23395003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kdm2b Regulates Somatic Reprogramming through Variant PRC1 Complex-Dependent Function.
    Zhou Z; Yang X; He J; Liu J; Wu F; Yu S; Liu Y; Lin R; Liu H; Cui Y; Zhou C; Wang X; Wu J; Cao S; Guo L; Lin L; Wang T; Peng X; Qiang B; Hutchins AP; Pei D; Chen J
    Cell Rep; 2017 Nov; 21(8):2160-2170. PubMed ID: 29166607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.
    Farcas AM; Blackledge NP; Sudbery I; Long HK; McGouran JF; Rose NR; Lee S; Sims D; Cerase A; Sheahan TW; Koseki H; Brockdorff N; Ponting CP; Kessler BM; Klose RJ
    Elife; 2012 Dec; 1():e00205. PubMed ID: 23256043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.
    Isshiki Y; Nakajima-Takagi Y; Oshima M; Aoyama K; Rizk M; Kurosawa S; Saraya A; Kondo T; Sakaida E; Nakaseko C; Yokote K; Koseki H; Iwama A
    Blood Adv; 2019 Sep; 3(17):2537-2549. PubMed ID: 31471323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Structural Elements of the Lysine Specific Demethylase 2B CxxC Domain Associated with Replicative Senescence Bypass in Primary Mouse Cells.
    Deiktakis EE; Abrams M; Tsapara A; Stournaras C; Tsatsanis C; Tsichlis PN; Kampranis SC
    Protein J; 2020 Jun; 39(3):232-239. PubMed ID: 32270414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes.
    He J; Shen L; Wan M; Taranova O; Wu H; Zhang Y
    Nat Cell Biol; 2013 Apr; 15(4):373-84. PubMed ID: 23502314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
    Tzatsos A; Paskaleva P; Ferrari F; Deshpande V; Stoykova S; Contino G; Wong KK; Lan F; Trojer P; Park PJ; Bardeesy N
    J Clin Invest; 2013 Feb; 123(2):727-39. PubMed ID: 23321669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Structure-Based Strategy for Engineering Selective Ubiquitin Variant Inhibitors of Skp1-Cul1-F-Box Ubiquitin Ligases.
    Gorelik M; Manczyk N; Pavlenco A; Kurinov I; Sidhu SS; Sicheri F
    Structure; 2018 Sep; 26(9):1226-1236.e3. PubMed ID: 30033217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cell proliferation and induction of autophagy by KDM2B/FBXL10 knockdown in gastric cancer cells.
    Zhao E; Tang C; Jiang X; Weng X; Zhong X; Zhang D; Hou J; Wang F; Huang M; Cui H
    Cell Signal; 2017 Aug; 36():222-229. PubMed ID: 28506929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts.
    Janzer A; Stamm K; Becker A; Zimmer A; Buettner R; Kirfel J
    J Biol Chem; 2012 Sep; 287(37):30984-92. PubMed ID: 22825849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.
    Kang JY; Kim JY; Kim KB; Park JW; Cho H; Hahm JY; Chae YC; Kim D; Kook H; Rhee S; Ha NC; Seo SB
    FASEB J; 2018 Oct; 32(10):5737-5750. PubMed ID: 29763382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
    Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells.
    Tzatsos A; Paskaleva P; Lymperi S; Contino G; Stoykova S; Chen Z; Wong KK; Bardeesy N
    J Biol Chem; 2011 Sep; 286(38):33061-9. PubMed ID: 21757686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.
    Kottakis F; Foltopoulou P; Sanidas I; Keller P; Wronski A; Dake BT; Ezell SA; Shen Z; Naber SP; Hinds PW; McNiel E; Kuperwasser C; Tsichlis PN
    Cancer Res; 2014 Jul; 74(14):3935-46. PubMed ID: 24853546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epigenetic factor KDM2B regulates cell adhesion, small rho GTPases, actin cytoskeleton and migration in prostate cancer cells.
    Zacharopoulou N; Tsapara A; Kallergi G; Schmid E; Tsichlis PN; Kampranis SC; Stournaras C
    Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):587-597. PubMed ID: 29408056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4.
    Chavdoula E; Anastas V; La Ferlita A; Aldana J; Carota G; Spampinato M; Soysal B; Cosentini I; Parashar S; Sircar A; Nigita G; Sehgal L; Freitas MA; Tsichlis PN
    Metabolism; 2024 Jan; 150():155719. PubMed ID: 37935302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.
    Johmura Y; Sun J; Kitagawa K; Nakanishi K; Kuno T; Naiki-Ito A; Sawada Y; Miyamoto T; Okabe A; Aburatani H; Li S; Miyoshi I; Takahashi S; Kitagawa M; Nakanishi M
    Nat Commun; 2016 Feb; 7():10574. PubMed ID: 26868148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling.
    Lađinović D; Pinkas D; Šopin T; Raška O; Liška F; Raška I; Vacík T
    PLoS One; 2020; 15(10):e0236612. PubMed ID: 33104714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.